FDA 483 - Telix IsoTherapeutics Group, Inc. - July 31, 2025

I cannot create a summary because the provided content consists only of page number references (e.g., 'Page 29 of 36') and does not contain the actual text of the FDA 483 inspection report. To generate a summary, please provide the full text of the document, including details such as the company name, inspection dates, observed violations, and any requested corrective actions.